Rockwell Medical (RMTI) Regains Nasdaq Compliance

Go back to Rockwell Medical (RMTI) Regains Nasdaq Compliance

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

June 1, 2022 8:00 AM EDT

WIXOM, Mich. , June 1, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that it received notice from The NASDAQ Stock Market LLC (NASDAQ) on May 31, 2022 informing Rockwell... More